India’s Cut-Price Generics Program Rebounds But Real Impact Still Limited

 
• By Anju Ghangurde
  
Indian Medicine
INDIA'S AMBITIOUS CUT-PRICE MEDICINES INITIATIVE STILL HAS A LONG WAY TO GO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia